in3

in3

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Edelweiss Connect (2 weeks ago)
RT @barryhardy: Weigh up your evidence carefully before reaching a conclusion. Evaluating the #skin #sensitisation potential of a squaric a…
Edelweiss Connect (2 weeks ago)
Integrated Approaches to solving Skin Safety Assessment problems #skinsafety #skincare #cosmetics #invitro… https://t.co/oUvJ1xByGf
Edelweiss Connect (4 weeks ago)
RT @sysrev1: ICYMI: Here is the full webinar - presented by #SaferWorldByDesign. https://t.co/PeeKfmRsk2 Founder @tomlue discusses #Sysrev…
Edelweiss Connect (4 weeks ago)
RT @LabsExplorer: New workflow to collect, analyse and report on #nanomaterials characterisation data from @edelweissconn. Find more about…
Edelweiss Connect (5 weeks ago)
RT @sysrev1: #Webinar by #SaferWorldByDesign: Sysrev - a collaborative platform for data extraction. March 3, 2020 @ 16:00 CET | 10:00 EST…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA